FDA Bashes Otsuka Bid To Block Abilify Generics
The U.S. Food and Drug Administration on Monday asked a Maryland federal judge not to block it from approving generic versions of Otsuka Pharmaceutical Co. Ltd.'s mega-blockbuster Abilify, saying there is...To view the full article, register now.
Already a subscriber? Click here to view full article